FDA Inspection 857298 — Omthera Pharmaceuticals
The FDA completed an inspection of Omthera Pharmaceuticals on Nov 5, 2013 in Princeton, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 5, 2013
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Princeton, NJ (United States)
Additional details
Sponsor, Contract Research Organization
Citations
| ID | CFR | Description |
|---|---|---|
| 7409 | 21 CFR 312.53(b) | Shipment to unauthorized persons |
| 7459 | 21 CFR 312.57(a) | Records of receipt, shipment, disposition |
| 7482 | 21 CFR 312.50 | General responsibilities of sponsors |